BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28065693)

  • 1. Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
    Zhou Q; Schötterl S; Backes D; Brunner E; Hahn JK; Ionesi E; Aidery P; Sticht C; Labeit S; Kandolf R; Gawaz M; Gramlich M
    Int J Cardiol; 2017 Mar; 230():634-641. PubMed ID: 28065693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
    Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
    J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
    Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy.
    Ferreira LR; Frade AF; Santos RH; Teixeira PC; Baron MA; Navarro IC; Benvenuti LA; Fiorelli AI; Bocchi EA; Stolf NA; Chevillard C; Kalil J; Cunha-Neto E
    Int J Cardiol; 2014 Aug; 175(3):409-17. PubMed ID: 24910366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy.
    Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
    J Card Fail; 2010 May; 16(5):404-10. PubMed ID: 20447577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.
    Makarenko I; Opitz CA; Leake MC; Neagoe C; Kulke M; Gwathmey JK; del Monte F; Hajjar RJ; Linke WA
    Circ Res; 2004 Oct; 95(7):708-16. PubMed ID: 15345656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 and microRNAs in cardiac tissues of patients with dilated cardiomyopathy.
    Wang Y; Li M; Xu L; Liu J; Wang D; Li Q; Wang L; Li P; Chen S; Liu T
    Mol Med Rep; 2017 Jan; 15(1):359-365. PubMed ID: 27922664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.
    Quattrocelli M; Crippa S; Montecchiani C; Camps J; Cornaglia AI; Boldrin L; Morgan J; Calligaro A; Casasco A; Orlacchio A; Gijsbers R; D'Hooge J; Toelen J; Janssens S; Sampaolesi M
    J Am Heart Assoc; 2013 Aug; 2(4):e000284. PubMed ID: 23963759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cellular microRNA, let-7i, is a novel biomarker for clinical outcome in patients with dilated cardiomyopathy.
    Satoh M; Minami Y; Takahashi Y; Tabuchi T; Nakamura M
    J Card Fail; 2011 Nov; 17(11):923-9. PubMed ID: 22041329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cardiac MicroRNAs safeguard against dilated cardiomyopathy.
    Cheng X; Jian D; Xing J; Liu C; Liu Y; Cui C; Li Z; Wang S; Li R; Ma X; Wang Y; Gu X; Ge Z; Tang H; Liu L
    Clin Transl Med; 2023 May; 13(5):e1258. PubMed ID: 37138538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.
    Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM
    Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
    Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
    J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Gab1 deletion leads to dilated cardiomyopathy associated with mitochondrial damage and cardiomyocyte apoptosis.
    Zhao J; Yin M; Deng H; Jin FQ; Xu S; Lu Y; Mastrangelo MA; Luo H; Jin ZG
    Cell Death Differ; 2016 Apr; 23(4):695-706. PubMed ID: 26517531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p.
    Bian C; Xu T; Zhu H; Pan D; Liu Y; Luo Y; Wu P; Li D
    PLoS One; 2015; 10(12):e0144877. PubMed ID: 26658785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial microRNAs associated with reverse remodeling in human heart failure.
    Sucharov CC; Kao DP; Port JD; Karimpour-Fard A; Quaife RA; Minobe W; Nunley K; Lowes BD; Gilbert EM; Bristow MR
    JCI Insight; 2017 Jan; 2(2):e89169. PubMed ID: 28138556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Titin Truncation Variant Linked to Familial Dilated Cardiomyopathy Found in a Japanese Family and Its Functional Analysis in Genome-Edited Model Cells.
    Hirayama-Yamada K; Inagaki N; Hayashi T; Kimura A
    Int Heart J; 2021 Mar; 62(2):359-366. PubMed ID: 33678800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
    Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
    Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A slow-releasing form of prostacyclin agonist (ONO1301SR) enhances endogenous secretion of multiple cardiotherapeutic cytokines and improves cardiac function in a rapid-pacing-induced model of canine heart failure.
    Shirasaka T; Miyagawa S; Fukushima S; Saito A; Shiozaki M; Kawaguchi N; Matsuura N; Nakatani S; Sakai Y; Daimon T; Okita Y; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):413-21. PubMed ID: 23541854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
    Calderon-Dominguez M; Belmonte T; Quezada-Feijoo M; Ramos M; Calderon-Dominguez J; Campuzano O; Mangas A; Toro R
    Sci Rep; 2021 Apr; 11(1):7517. PubMed ID: 33824379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.